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Abstract: Overproduction of reactive oxygen and nitrogen species leads to oxidative stress and decreased total antioxidant capacity,
which is responsible for high mortality from several diseases such as endotoxic shock. Nitric oxide (NO) produced by inducible NO
synthase (iNOS) during endotoxemia is the major cause of vascular hyporeactivity, hypotension and multiple organ failure. We
investigated whether NO-mediated oxidative stress in rat heart, aorta and mesenteric artery is involved in the attenuation of
endotoxin-induced hypotension by inhibition of iNOS. In conscious male Wistar rats, injection of endotoxin (10 mg/kg, i.p.) caused
a gradual fall in mean arterial pressure (MAP) for 4 hours and increased serum and tissue nitrite levels. These effects of endotoxin
were prevented by selective inhibition of iNOS with phenylene-1,3-bis[ethane-2-isothiourea] dihydrobromide (1,3-PBIT) (10 mg/kg,
i.p.; 1 hour after endotoxin). Myeloperoxidase (MPO) activity was increased in the heart and aorta and decreased in the mesenteric
artery by endotoxin which was reversed by 1,3-PBIT. Endotoxin caused a decrease in products of lipid peroxidation in the tissues,
which is prevented by 1,3-PBIT. These data suggest that NO-mediated decrease in MAP during endotoxemia is associated with
decreased oxidative stress in the heart, aorta and mesenteric artery and that the beneficial effects of iNOS inhibitors on the
endotoxin-induced hypotension may be due to restoration of total antioxidant capacity.
Key Words: Rat, endotoxin, hypotension, inducible nitric oxide synthase, lipid peroxidation

Introduction
Oxidative stress results from an oxidant/antioxidant
imbalance, an excess of oxidants and/or a depletion of
antioxidants. The excessive production of reactive oxygen
and nitrogen species (ROS and RNS, respectively)
associated with inflammation leads to oxidative stress,
which is involved in the high mortality from several
diseases such as endotoxic shock (1-4). There is a
considerable body of evidence for redox imbalance and
oxidative stress in endotoxic shock. It has been reported
that endotoxemia increases markers of oxidative stress

and tissue injury in different animal models and in
humans. This effect of endotoxin has been found to be
correlated with decreased total antioxidant potential and
blood levels of several antioxidants such as α-tocopherol,
retinol, vitamin E, vitamin C and β-carotene in humans
with sepsis and septic shock (1-4). It has also been
reported that although total antioxidant capacity was
decreased in patients with sepsis, it was increased in
patients with septic shock (5). Increased xanthine
oxidase, superoxide dismutase and glutathione peroxidase
activity has also been reported in patients with sepsis,

* A part of this this work presented at 18th National Congress of Pharmacology, ‹zmir, Turkey, September 28-October 1, 2005.
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suggesting increased production of ROS (6). However,
malondialdehyde (MDA) (an index for lipid peroxidation)
levels were also increased, suggesting that the elevations
of these antioxidant enzymes were not effective enough
to prevent cellular damage.
Among RNS, nitric oxide (NO) derived from inducible
NO synthase (iNOS) is considered to be the major cause of
systemic hypotension, vascular hyporeactivity, multiple
organ failure and high mortality rate associated with
septic shock (4,7). Although the role of NO is
controversial in tissue injury with oxidative DNA damage
in endotoxemia, most of the clinical trials demonstrate
that iNOS inhibitors may serve as a potentially effective
pharmacological agents in alleviating endotoxin-induced
decrease in antioxidant capacity and tissue injuries (1, 4,
7).
The purpose of this study was to determine whether
NO-mediated oxidative stress in the heart, aorta and
mesenteric artery from endotoxemic rats is involved in
the attenuation of systemic hypotension by selective
inhibition of iNOS.
Materials and Methods

mean arterial blood pressure (MAP) and heart rate were
measured using the tail-cuff method at 0, 1, 2, 3 and 4
hours. Separate groups of rats were treated with
endotoxin alone or in combination with the highly
selective iNOS inhibitor 1,3-PBIT (10 mg/kg, i.p.) at 1
hour after injection of saline or endotoxin. Rats were
sacrificed 4 hours after the endotoxin challenge, and
blood from the heart, aorta and mesenteric artery were
collected. Sera were obtained from blood samples by
centrifugation at 18.000 rpm for 15 minutes at 4 °C and
stored at –20 °C until analyzed for the measurement of
nitrite levels. The tissues were homogenized in ice-cold
buffer (1 ml) (mM: HEPES 20 [pH 7.5], βglycerophosphate 20, sodium pyrophosphate 20; sodium
orthovanadate 0.2, EDTA 2, sodium fluoride 20,
benzamidine 10, dithiothreitol 1, leupeptin 20 and
aprotinin 10) (8). Cell debris was removed by
centrifugation at 18.000 rpm for 15 minutes at 4 °C
followed by sonication for 15 seconds on ice with 50 µL
ice-cold Tris (50 mM, pH 8.0) and KCl (0.5 M). The
samples were centrifuged at 18.000 rpm for 15 minutes
at 4 °C and then supernatants were removed and stored
at -20 °C until analyzed for the measurement of
myeloperoxidase (MPO) activity and protein, nitrite and
malondialdehyde (MDA) levels.

Chemicals
Endotoxin (lipopolysaccharide, Escherichia coli
O111:B4),
phenylene-1,3-bis[ethane-2-isothiourea]
dihydrobromide (1,3-PBIT), sodium nitrite, bovine serum
albumin (BSA) and Bradford reagent were purchased
from Sigma Chemical Co. (St. Louis, U.S.A.). Other
chemicals were obtained from Merck (Darmstadt,
Germany). All drugs were prepared daily in distilled water
or saline.
Animals and endotoxic shock model
Male Wistar rats weighing 250 to 350 g were fed
standard chow. They were synchronised by maintenance
of controlled environmental conditions throughout the
duration of the experiments. The circadian rhythmicity of
the animals were entrained by a standardised 12 h light
and 12 h dark period. All animal experiments were
carried out according to the proposal of the U.S. National
Institutes of Health Guide for the Care and Use of
Laboratory Animals. The protocol was approved by the
ethics committee of Mersin University School of Medicine.
Conscious rats received either endotoxin (10 mg/kg, i.p.,
sublethal dose) or saline (4 ml/kg, i.p.) at time 0 and
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Measurement of tissue protein content
The protein content in the tissue homogenates was
determined according to Coomassie blue method using
BSA for standard (9). Briefly, Bradford reagent (200 µl)
was added to the mixture of tissue homogenate (5 µl) and
distilled water (795 µl). Samples (100 µl) were then
pipetted into 96 well microtiter plates and absorbance
was measured at 620 nm with a microplate reader
(Organo Teknika Microwell System, Holland). Linear
regression analysis was used to calculate the protein
amount in the tissue homogenates from the standard
calibration curves of BSA.
Measurement of serum and tissue nitrite levels
In biological systems conversion of NO in aqueous
solution to nitrite and nitrate is thought to favour nitrite
production (10). It has been reported that nitrite is the
only stable end-product of the autooxidation of NO in
aqueous solution (11) and measurement of nitrite
concentrations in the serum and tissue homogenates is
widely accepted as an index of NOS activity (7, 12-14).
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Therefore, concentrations of nitrite in serum and tissue
homogenates were measured by using the diazotization
method based on the Griess reaction, which is an indirect
assay for NO production (12). Briefly, samples (50 µl)
were pipetted into 96 well microtiter plates and an equal
volume of Griess reagent (1% sulphanylamide (25 µl) and
0.1% N-1-naphtylethylenediamine dihydrochloride (25
µl) in 2.5% ortophosphoric acid) was added to each well.
After incubation for 10 minutes at room temperature,
absorbance was measured at 540 nm with a microplate
reader (Organo Teknika Microwell System, Holland).
Linear regression analysis was used to calculate the nitrite
concentrations in the sera and the tissue homogenates
from the standard calibration curves of sodium nitrite.
Serum and tissue nitrite levels were expressed as µM or
mmol/mg protein, respectively.

Measurement of tissue MPO activity
MPO is a haem-containing enzyme within the
azurophil granules of neutrophils and MPO activity was
measured as a simple quantitative method of detecting
leukosequestration. The determination of MPO activity as
an index of neutrophil infiltration in tissue homogenates
depends on the fact that oxidized hidrogen peroxide
reduces o-dianisidine (15). Reduced o-dianisidine was
measured at 410 nm by spectrophotometer. One unit of
MPO activity was defined as that degrading 1 µmol of
hydrogen peroxide to water per minute at 25 °C. Tissue
MPO activity was expressed as U/mg protein.

Measurement of tissue MDA levels
As an index of lipid peroxidation, the levels of MDA in
tissue homogenates were determined by thiobarbituric
acid reaction according to Yagi (16). The method depends
on the measurement of the pink color produced by
interaction of the barbituric acid with MDA caused by lipid
peroxidation. Linear regression analysis was used to
calculate the MDA levels in the tissue homogenates from
the standard calibration curves of 1,1,3,3tetraethoxypropane. Tissue MDA levels were expressed as
mmol/mg protein.
Statistical analysis
All data were expressed as means ± SEM. Data were
analyzed by one-way ANOVA followed by StudentNewman-Keuls test for multiple comparisons and

unpaired Student’s t or Mann-Whitney U tests when
necessary. P value of < 0.05 was considered to be
statistically significant.
Results
Endotoxin-induced fall in MAP is mediated by NO
produced by iNOS
Injection of endotoxin caused a gradual fall in MAP
reaching from 134 ± 4 mmHg (n = 8) at 0 time to 109
± 5 mmHg (n = 6) at 4 hours (P < 0.05) (Table 1).
Endotoxin also caused a gradual increase in heart rate
reaching from 339 ± 11 beats/min (n = 12) at 0 time to
422 ± 14 beats/min (n = 7) at 4 hours (P < 0.05) (Table
1). We chose this time point in all our experiments so that
we could measure changes in endotoxin-induced decrease
in MAP and increase in heart rate caused by various
interventions.
In order to evaluate the contribution of iNOS-derived
NO to the endotoxin-induced hypotension, the selective
inhibitor of iNOS, 1,3-PBIT, was injected to the animals
alone or in combination with endotoxin. Endotoxininduced decrease in MAP (Figure 1A) and increase in
heart rate (Figure 1B) were blunted by the administration
of 1,3-PBIT. While 1,3-PBIT alone had no effect on MAP
(Figure 1A), heart rate was decreased by 1,3-PBIT
(Figure 1B).
Endotoxin-induced rise in systemic and tissue
nitrite levels is decreased by iNOS inhibitor, 1,3-PBIT
In order to evaluate the contribution of iNOS-derived
NO to the endotoxin-induced decrease in MAP and
increase in heart rate, nitrite levels were measured in
serum and tissues from 1,3-PBIT-injected animals. The
endotoxin-induced decrease in MAP and increase in heart
rate were associated with an increase in the nitrite levels
in serum (Figure 2A), heart (Figure 2B), aorta (Figure
2C) and mesenteric artery (Figure 2D). Endotoxininduced increase in nitrite production in serum and the
tissues was blunted by the administration of 1,3-PBIT
(Figure 2). 1,3-PBIT had no effect on basal serum and
tissue nitrite levels (Figure 2).
Endotoxin produces different effects on tissue
MPO activity
To investigate the effect of endotoxin on neutrophil
infiltration as an index for the development of
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Table 1. Effect of 1,3-PBIT on mean arterial pressure (MAP) and heart rate in endotoxemic rats.

Time after endotoxin injection (hours)
0

1

2

3

4

MAP (mmHg)

128 ± 8

149 ± 13

136 ± 4

136 ± 6

138 ± 5

(n = 6)

(n = 5)

(n = 6)

(n = 5)

(n = 5)

Heart rate (beats/min)

343 ± 8

336 ± 10

319 ± 4

336 ± 10

344 ± 10

(n = 6)

(n = 6)

(n = 6)

(n = 6)

(n = 6)

MAP (mmHg)

134 ± 4

107 ± 8*■

106 ± 6*■

111 ± 8*■

109 ± 5*■

(n = 8)

(n = 8)

(n = 8)

(n = 5)

(n = 6)

Heart rate (beats/min)

339 ± 11

397 ± 17*■

420 ± 9*■

419 ± 13*■

422 ± 14*■

(n = 12)

(n = 10)

(n = 7)

(n = 5)

(n = 7)

MAP (mmHg)

139 ± 3

142 ± 1

140 ± 3

140 ± 2

146 ± 3

(n = 6)

(n = 6)

(n = 6)

(n = 6)

(n = 6)

Heart rate (beats/min)

319 ± 8

318 ± 5

307 ± 2*

300 ± 5*

301 ± 9*

(n = 6)

(n = 6)

(n = 6)

(n = 6)

(n = 6)

MAP (mmHg)

140 ± 4

121 ± 4*▲■

124 ± 1*+▲■

129 ± 2+▲●

129 ± 7+▲

(n = 6)

(n = 6)

(n = 6)

(n = 6)

(n = 5)

Heart rate (beats/min)

318 ± 1

384 ± 3+▲■

383 ± 15+▲■

366 ± 8+▲■

380 ± 10+▲■

(n = 6)

(n = 6)

(n = 5)

(n = 6)

(n = 6)

Control

ET

1,3-PBIT

ET+1,3-PBIT

MAP and heart rate measurements were performed in rats treated with saline (control) or endotoxin (ET; 10 mg/kg, i.p.) or in endotoxemic rats
treated with 1,3-PBIT (10 mg/kg, i.p.). The inhibitor, alone or in combination with ET, were injected at 1 hour after endotoxin. Data are expressed
as mean ± SEM (n = 5-12). * P < 0.05 vs. saline-treated group (vehicle) determined by using unpaired Student's t or Mann-Whitney U tests.
0.05 vs. ET-treated group determined by using unpaired Student's t or Mann-Whitney U tests.

▲

+

P<

P < 0.05 vs. 1,3-PBIT-treated group determined

by using unpaired Student's t or Mann-Whitney U tests. ■ P < 0.05 vs. time 0 value determined by using one-way ANOVA followed by Student-Newman-Keuls test for multiple comparisons test. ● P < 0.05 vs. time 1 value determined by using one-way ANOVA followed by Student-Newman-Keuls
test for multiple comparisons test.

inflammation, MPO activity was measured in the tissues
from endotoxemic animals. Endotoxemia increased MPO
activity in heart (Figure 3A) and aorta (Figure 3B), which
is prevented by 1,3-PBIT. On the other hand, endotoxin
caused a decreased MPO activity in mesenteric artery
which is also blunted with 1,3-PBIT (Fig 3C). 1,3-PBIT
had no effect on tissue MPO activity (Figure 3).
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Endotoxin-induced increase in systemic and tissue
nitrite levels are associated with decreased oxidative
stress
To investigate the effect of endotoxin on oxidative
stress, one of the products of lipid peroxidation, MDA,
was measured in the tissues from endotoxemic animals.
Endotoxin decreased MDA levels in the heart (Figure 4A),
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Mean Arterial Pressure (mmHg)

150

inflammation in conscious rats, and NO-derived from the
heart, aorta and mesenteric artery contributes to these
effects of endotoxin. More importantly, we showed that
endotoxemia-induced increase in NO production
suppresses lipid peroxidation in cardiac and vascular
tissue and selective inhibition of iNOS with 1,3-PBIT
restores tissue antioxidant capacity and consequently
MAP, presumably due to decreased levels of antioxidant
molecules or activities of antioxidant enzyme systems.

A

125

100
Vehicle

ET

1,3-PBIT

ET+1,3-PBIT

450

Heart rate (beats/min)

B

400

350

300
Vehicle

ET

1,3-PBIT

ET+1,3-PBIT

Figure 1. Effect of iNOS inhibition by 1,3-PBIT on mean arterial
pressure (MAP) (A) and heart rate (B) 4 h after saline
(vehicle) or endotoxin (ET) injection in conscious rats. 1,3PBIT was given at 1 h after ET injection. Values are
expressed as means ± SEM from 5-7 rats per treatment
group. * P < 0.05 vs. saline-treated group (vehicle)
determined by using unpaired Student's t test. + P < 0.05
vs. ET-treated group determined by using unpaired
Student's t test. ▲ P < 0.05 vs. 1,3-PBIT-treated group
determined by using unpaired Student's t test.

aorta (Figure 4B) and mesenteric artery (Figure 4C)
which is prevented by 1,3-PBIT. 1,3-PBIT had no effect
on basal MDA levels in the tissues (Figure 4).

Discussion
This study demonstrates that increased NO production
by iNOS 4 hour after endotoxin injection causes
hypotension associated with cardiac and aortic

Expression of iNOS protein and mRNA expression
approximately 3 hours after systemic endotoxin
administration to animals has been reported in several
tissues, including several blood vessels, heart, kidney and
lung associated with significant increase in serum/plasma
and tissue nitrite levels and decrease in MAP (7,17-19).
In the present study, administration of endotoxin to rats
decreased MAP at 4 hour. This was associated with an
increase in the serum nitrite levels that was prevented
after selective inhibition of iNOS with 1,3-PBIT.
Endotoxin-induced increase in heart, aorta and
mesenteric artery nitrite production was also blunted by
1,3-PBIT. These observations suggest that NO produced
mainly by activation of iNOS contributes to the endotoxininduced hypotension in conscious rats.
There are contradictory reports in the literature
concerning the role of NO as an antiinflammatory or
proinflammatory agent (7,17,18). In the present study,
we found that endotoxin caused an increased level of
nitrite in serum, heart and aorta as well as increased MPO
activity prevented by the iNOS inhibitor, 1,3-PBIT.
However, increased levels of nitrite in the mesenteric
artery was associated with decreased MPO activity, also
reversed by 1,3-PBIT. These results suggest that NO
produced by iNOS, expressed in, at least the heart and
aorta, acts as an proinflammatory mediator in this
endotoxemia model in rat. On the other hand, endotoxininduced decrease in MPO activity in the mesenteric artery
suggests that iNOS-derived NO acts as an antiinflammatory mediator to protect small resistance
arteries which are responsible for maintaining blood
pressure under pathological conditions from detrimental
effects of endotoxin.
It is well known that oxidative stress results from an
oxidant/antioxidant imbalance, an excess of oxidants
and/or a depletion of antioxidants (4). Although increased
activity of antioxidant enzymes such as xanthine oxidase,
superoxide dismutase and glutathione peroxidase has
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Figure 2. Effect of iNOS inhibition by 1,3-PBIT on changes in serum (A), heart (B), aorta (C) and mesenteric artery (D) nitrite levels 4 h after saline
or endotoxin (ET) injection in conscious rats. Values are expressed as means ± SEM from 3-10 rats per treatment group. * P < 0.05 vs.
saline-treated group (vehicle) determined by using unpaired Student's t or Mann-Whitney U tests. + P < 0.05 vs. ET-treated group
determined by using unpaired Student's t test.

been reported in patients with sepsis, MDA levels have
also been shown to be increased, suggesting that the
elevations of these antioxidant enzymes were not
sufficrently effective to prevent cellular damage (5).
Moreover, Mirochnitchenko et al. (20) have reported that
transgenic mice overexpressing 2 major forms of human
glutathione peroxidases (GPs), intra- and extracellular
GP, are able to modulate host response during
endotoxemic conditions. They also showed that these
animals had decreased hypotension and increased
survival rate after administration of a high dosage of
endotoxin. In the present study, endotoxin-induced
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increase in the nitrite levels in serum, heart, aorta and
mesenteric artery was associated with decreased MDA
levels in these tissues and prevented by 1,3-PBIT.
Although there are conflicting reports on the effect of NO
on lipid peroxidation and oxidative stress (21-24), our
results are also consistent with the observations that NO
behaves as a potent antioxidant. Indeed, it has been
demonstrated that addition of NO as a saturated aqueous
solution to human leukemia cells (25) and rat brain
homogenates under aerobic conditions (26) decreases
lipid peroxidation. Levels of MDA have also been shown to
be decreased during NO inhalation in rats (27). NO
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Figure 3. Effect of iNOS inhibition by 1,3-PBIT on changes in heart
(A), aorta (B) and mesenteric artery (C) myeloperoxidase
(MPO) activity 4 h after saline or endotoxin (ET) injection in
conscious rats. Values are expressed as means ± SEM in 39 rats per treatment group. * P < 0.05 vs. saline-treated
group (vehicle) determined by using unpaired Student's t
test. + P < 0.05 vs. ET-treated group determined by using
unpaired Student's t test.

Figure 4. Effect of iNOS inhibition by 1,3-PBIT on changes in heart
(A), aorta (B) and mesenteric artery (C) malondialdehyde
(MDA) levels 4 h after saline or endotoxin (ET) injection in
conscious rats. Values are expressed as means ± SEM in 48 rats per treatment group. * P < 0.05 vs. saline-treated
group (vehicle) determined by using unpaired Student's t or
Mann-Whitney U tests. + P < 0.05 vs. ET-treated group
determined by using unpaired Student's t test.
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donors, such as nitroglycerine in coronary artery bypass
surgery (28), stress-induced gastric mucosal damage
(29) and physical training (30), glyceryltrinitrate in ferric
nitrilotriacetate-induced oxidative stress (31) stressinduced gastric mucosal damage (32), sodium
nitroprusside in carbon tetrachloride-induced liver injury
(33), 3-morpholinosydnonimine in stress-induced gastric
mucosal damage (29), S-nitroso-N-acetylpenicillamine in
stress-induced gastric mucosal damage (29),
hypoxia/regeneration-induced damage of brain-blood
barrier cells (34) iron-catalyzed brain lipid peroxidation
(35), diethylamine NONOate in rat brain homogenates
under aerobic conditions (26), molsidomine in intestinal
ischemia-reperfusion injury (36), O(2)-vinyl 1-(pyrrolidinacetaminophen
1-yl)diazen-1-ium-1,2-diolate
in
nephrotoxicity (37) or nitric oxide-releasing aspirin in
stress-induced gastric mucosal damage (29,32,38) have
also been reported to cause an attenuation of lipid
peroxidation as documented by a decrease of tissue MDA
levels in rats and mice as well as in humans. Moreover the
NO precursor, L-arginine has been shown to decrease
blood and/or tissue MDA levels in several disease models
in animals with hypercholesterolemia and atherosclerosis
(39), hypoxia/reoxygenation-induced intestinal injury
(40), burn injury (41), hypoxia/reoxygenation-induced
necrotizing enterocolitis, warm ischemia-reperfusion
injury (42), hypoxia-induced tissue damage (43) and
hypoxemic/reoxygenation injury (44) as well as in humans
during coronary artery bypass surgery (45). On the other
hand, tissue and/or plasma MDA levels have been
reported to increase after in vitro incubation of tissues or
systemic administration of NO donors, such as cyanamide
(29), SNP (46-48), isosorbide dinitrate (49) or SNAP
(50) in rats. Tissue MDA levels have also been shown to
be increased after L-arginine treatment in the renal
ischemia-reperfusion model in rat (51,52), 2,4,6trinitrobenzenesulfonic acid induced colitis in rat (53) and
myocardial stunning in dogs (54). There are several
reports indicating that systemic administration of
inhibitors of lipid peroxidation, anthocyanins (55), potent
antioxidants such as ascorbic acid (56) and melatonin
(57), a dual vitamin E-like antioxidant and inhibitor of
nuclear factor-κB, IRFI 042 (58), ethyl pyruvate (59), U-

83836E (60), an alpha/beta-adrenoceptor and
serotonergic receptor blocker, eugenosedin-A (56) and
the tyrosine kinase inhibitor genistein (61), result in
improved hemodynamic status and reversal of endotoxic
shock. The protective effects of these agents have been
attributed to their antioxidant properties and also
inhibition of cytokine and/or NO overproduction. Based
on our findings and previous studies, therefore, it can be
concluded that NO produced by iNOS mediates the
endotoxin-induced increased total antioxidant capacity
and consequently decreases lipid peroxidation.
In summary, overproduction of NO during
endotoxemia leads to cardiac and aortic inflammation and
suppression of lipid peroxidation in cardiac and vascular
tissue. Selective inhibition of iNOS with 1,3-PBIT restores
tissue inflammation and antioxidant capacity and
consequently MAP, presumably due to decreased levels of
antioxidant molecules or activities of antioxidant enzyme
systems. Impairment of cardiovascular function is
critically involved in the pathophysiological sequalae in
septic shock finally resulting in multiorgan failure and
death; restoration of these impaired functions should
improve therapeutic benefit. Our results suggest that
treatment with the selective iNOS could improve the
cardiovascular function associated with inflammation and
increased antioxidant capacity in patients during septic
shock.
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